Bu liste, son piyasa olaylarına dayalı bir analizdir. Yatırım tavsiyesi değildir.
Hakkında
Asymchem Laboratories (Tianjin) Co., Ltd. provides clinical stage CDMO, commercial stage CDMO, and emerging services in Mainland China and internationally. The company offers API solutions, such as small molecules, highly potent, carbapenems, glycans, peptides, oligonucleotides, and therapeutic enzymes; GMP, non-GMP, asymchem lab facilities and capabilities, commercial manufacturing, clinical manufacturing, separations, crystallization, fermentation, continuous FlowGMP, non-GMP, Asymchem lab facilities and capabilities, commercial manufacturing, clinical manufacturing, separations, crystallization, fermentation, and continuous flow; and chemical process R&D, analytical services, regulatory, pre-clinical R&D support, PPQ readiness, and back integration services. It also engages in technology services comprising flow chemistry, biocatalysis, fermentation, chiral synthesis, hazardous reactions, low temperature, highly potent, non-precious metal catalysis (NPMC), high-pressure chemistry, electrochemistry, and photochemistry. In addition, the company offers drug products, such as pharma solutions, preformulation, solid oral dosage, and injectables; and biotech solutions, drug substance and development, and consultation services. The company was founded in 1998 and is headquartered in Tianjin, China.
Borsaya bağlı olarak hisse sembolü değişebilir. Örneğin, borsasında Asymchem Laboratories (Tianjin) hisseleri ASLTY sembolüyle işlem görür.
Asymchem Laboratories (Tianjin) bir sonraki finansal sonuçlarını ne zaman açıklayacak?▼
Asymchem Laboratories (Tianjin), bir sonraki finansal raporunu Nisan 23, 2026 tarihinde açıklayacak.
Asymchem Laboratories (Tianjin)’in geçen çeyrekteki finansal sonuçları nasıldı?▼
ASLTY’in son çeyrek finansal sonuçları hisse başına 0.07 USD oldu, tahmin ise 0 USD idi ve +∞%’lik bir sürpriz oluştu. Gelecek çeyrek için tahmini sonuçlar hisse başına Yok USD olarak bekleniyor.